Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Comparative Studies Will Be Funded By Neurontin Settlement

Executive Summary

The Pfizer Neurontin off-label promotion settlement will fund $28 mil. in comparative efficacy studies for prescription drug products

You may also be interested in...



Academic Archive of Pharma Marketing Data On Hold Without Funding

A UCSF group wants its Internet site to be a go-to place for internal documents that reveal the marketing behavior of pharma companies. But it may be awhile before the site can resume posting data unearthed in litigation.

Academic Archive of Pharma Marketing Data On Hold Without Funding

A UCSF group wants its Internet site to be a go-to place for internal documents that reveal the marketing behavior of pharma companies. But it may be awhile before the site can resume posting data unearthed in litigation.

Neurontin Off-Label Suit: Plaintiffs’ Experts Claim Pfizer Slanted Studies

Pharmaceutical companies appear to be facing wider legal pressure to alter the way they create and disseminate studies designed to support marketed products

Related Content

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel